Related references
Note: Only part of the references are listed.A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway
Wenjing Mao et al.
LASERS IN MEDICAL SCIENCE (2016)
Nitidine chloride inhibits ovarian cancer cell migration and invasion by suppressing MMP-2/9 production via the ERK signaling pathway
Xiangxiu Sun et al.
MOLECULAR MEDICINE REPORTS (2016)
Colorimetric method for rapid detection of Oxacillin resistance in Staphylococcus aureus and its comparison with PCR for mec A gene
Niraj Ghanwate et al.
SCIENTIFIC REPORTS (2016)
The role of kinin receptors in cancer and therapeutic opportunities
Patricia L. N. da Costa et al.
CANCER LETTERS (2014)
Unmet needs and challenges in gastric cancer: The way forward
Florian Lordick et al.
CANCER TREATMENT REVIEWS (2014)
Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype
Ana Ferro et al.
EUROPEAN JOURNAL OF CANCER (2014)
Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells
Guojun Wang et al.
ONCOLOGY REPORTS (2014)
CXC chemokines and chemokine receptors in gastric cancer: From basic findings towards therapeutic targeting
Hyo Jin Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Carboxypeptidase M augments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide output
Xianming Zhang et al.
BIOLOGICAL CHEMISTRY (2013)
Multiple Factors from Bradykinin-Challenged Astrocytes Contribute to the Neuronal Apoptosis: Involvement of Astroglial ROS, MMP-9, and HO-1/CO System
Chuen-Mao Yang et al.
MOLECULAR NEUROBIOLOGY (2013)
Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant
A. Gomis et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCδ/c-Src dependent signaling pathway
Hsin-Shan Yu et al.
PROSTATE (2013)
Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer
Gab-Yong Bae et al.
ONCOTARGET (2013)
NADPH oxidase 2-derived reactive oxygen species signal contributes to bradykinin-induced matrix metalloproteinase-9 expression and cell migration in brain astrocytes
Chih-Chung Lin et al.
CELL COMMUNICATION AND SIGNALING (2012)
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - Differential treatment strategies for subtypes of early gastroesophageal cancer
Manfred P. Lutz et al.
EUROPEAN JOURNAL OF CANCER (2012)
Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems
Delphine Charignon et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2011)
Activation of kinin B1 receptor increases the release of metalloproteases-2 and-9 from both estrogen-sensitive and -insensitive breast cancer cells
Pamela Ehrenfeld et al.
CANCER LETTERS (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells - analysis of the molecular mechanisms of its antiproliferative action
Stephanie Jutras et al.
FEBS JOURNAL (2010)
Stimulation of the bradykinin B1 receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway
Luis Molina et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer
Jessica Chee et al.
BIOLOGICAL CHEMISTRY (2008)
Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-δ-dependent ERK/Elk-1 pathway in astrocytes
Hsi-Lung Hsieh et al.
GLIA (2008)
Participation of kallikrein-kinin system in different pathologies
Claudio M. Costa-Neto et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma
Sufi Mary Thomas et al.
CANCER RESEARCH (2006)
Tissue kallikrein and kinin receptor expression in an angiogenic co-culture neuroblastoma model
S. Naidoo et al.
METABOLIC BRAIN DISEASE (2006)
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group
K. Warren et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Targeting the ERK signaling pathway in cancer therapy
M Kohno et al.
ANNALS OF MEDICINE (2006)
Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin
S Greco et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture
S Greco et al.
JOURNAL OF ENDOCRINOLOGY (2005)
The kallikrein-kinin system: Current and future pharmacological targets
ME Moreau et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells
S Greco et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Scaffold proteins in mammalian MAP kinase cascades
K Yoshioka
JOURNAL OF BIOCHEMISTRY (2004)
Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells
L Barki-Harrington et al.
BIOCHEMICAL JOURNAL (2003)
Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues
J Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Comparison of tissue kallikrein and kinin receptor expression in gastric ulcers and neoplasms
S Sawant et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Kinin receptors in pain and inflammation
R Couture et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Bradykinin induced mitogenesis of androgen independent prostate cancer cells
L Barki-Harrington et al.
JOURNAL OF UROLOGY (2001)
Metabolism-resistant bradykinin antagonists: Development and applications
JM Stewart et al.
BIOLOGICAL CHEMISTRY (2001)
In various tumour cell lines the peptide bradykinin B2 receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist
S Drube et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
